Published in Best Pract Res Clin Endocrinol Metab on June 01, 2009
Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy. J Thromb Thrombolysis (2012) 1.00
Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol (2011) 0.98
Determinants to optimize response to clopidogrel in acute coronary syndrome. Pharmgenomics Pers Med (2010) 0.87
Antiplatelet resistance in stroke. Expert Rev Neurother (2011) 0.85
Risk factors for clopidogrel resistance in patients with ischemic cerebral infarction and the correlation with ABCB1 gene rs1045642 polymorphism. Exp Ther Med (2014) 0.76
Prevalence and risk factors of clopidogrel non-response among Saudi patients undergoing coronary angiography. Saudi Med J (2016) 0.75
State-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus. Curr Cardiovasc Risk Rep (2015) 0.75
Analysis of the metabolic properties of maintenance hemodialysis patients with glucose-added dialysis based on high performance liquid chromatography quadrupole time-of-flight mass spectrometry. Ther Clin Risk Manag (2013) 0.75
Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel. Thromb J (2017) 0.75
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development. Expert Opin Pharmacother (2008) 0.83
Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists. Catheter Cardiovasc Interv (2009) 0.82
Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction. Am Heart J (2008) 0.75